Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2024 Filed Aug 13, 2024 20:38 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
GrantCommon Stock | 15,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021183 · form4-08132024_080841.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,573 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:37 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
GrantStock Option (Right to Purchase) · Derivative | 77,255 | $0.00 Strike: $68.20 | $0.00 |
DisclosureSEC source: 0001415889-24-021180 · form4-08132024_080843.xml · derivative · entry 10 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,543 Underlying: Common Stock · 77,255 shares Expires 2029-08-09 F4 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:37 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
GrantCommon Stock | 28,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021180 · form4-08132024_080843.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,349,058 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:36 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
GrantStock Option (Right to Purchase) · Derivative | 13,742 | $0.00 Strike: $68.20 | $0.00 |
DisclosureSEC source: 0001415889-24-021176 · form4-08132024_080847.xml · derivative · entry 4 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,742 Underlying: Common Stock · 13,742 shares Expires 2034-08-09 F3 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:36 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
GrantCommon Stock | 15,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021176 · form4-08132024_080847.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,500 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:35 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
GrantStock Option (Right to Purchase) · Derivative | 5,486 | $0.00 Strike: $62.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021173 · form4-08132024_080845.xml · derivative · entry 2 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,486 Underlying: Common Stock · 5,486 shares Expires 2034-08-09 F2 · derivative.exercise_date: The Stock Options granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:35 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
GrantCommon Stock | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021173 · form4-08132024_080845.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,889 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 9, 2024 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:07 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
Tax withholdingCommon Stock | 2,174 | $62.16 | $135,135.84 |
DisclosureSEC source: 0001415889-24-020902 · form4-08072024_080804.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,551 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:05 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Tax withholdingCommon Stock | 2,174 | $62.16 | $135,135.84 |
DisclosureSEC source: 0001415889-24-020896 · form4-08072024_080807.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,320,751 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:03 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
Tax withholdingCommon Stock | 988 | $62.16 | $61,414.08 |
DisclosureSEC source: 0001415889-24-020889 · form4-08072024_080834.xml · nonDerivative · entry 2 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,394 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:07 UTC |
Munch MarkEXEC VP&PRES BRUKER NANO INC.
|
Tax withholdingCommon Stock | 986 | $63.54 | $62,650.44 |
DisclosureSEC source: 0001415889-24-020902 · form4-08072024_080804.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · EXEC VP&PRES BRUKER NANO INC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,725 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:05 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Tax withholdingCommon Stock | 3,582 | $63.54 | $227,600.28 |
DisclosureSEC source: 0001415889-24-020896 · form4-08072024_080807.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,322,925 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:03 UTC |
Herman Gerald NEXECUTIVE VICE PRESIDENT, CFO
|
Tax withholdingCommon Stock | 577 | $63.54 | $36,662.58 |
DisclosureSEC source: 0001415889-24-020889 · form4-08072024_080834.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · EXECUTIVE VICE PRESIDENT, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,382 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:05 UTC |
Requardt Hermann FritzDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006998 · form4-03062024_040303.xml · derivative · entry 6 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:05 UTC |
Requardt Hermann FritzDirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 5,000 | $0.00 Strike: $18.15 | $0.00 |
DisclosureSEC source: 0001415889-24-006998 · form4-03062024_040303.xml · derivative · entry 5 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2015-08-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option granted to the Reporting Person on August 25, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:05 UTC |
Requardt Hermann FritzDirector
|
SaleCommon Stock | 1,228 | $89.61 | $110,041.08 |
DisclosureSEC source: 0001415889-24-006998 · form4-03062024_040303.xml · nonDerivative · entry 4 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,147 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.60 to $89.64, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:05 UTC |
Requardt Hermann FritzDirector
|
SaleCommon Stock | 13,772 | $90.10 | $1,240,857.20 |
DisclosureSEC source: 0001415889-24-006998 · form4-03062024_040303.xml · nonDerivative · entry 3 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,375 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.70, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:05 UTC |
Requardt Hermann FritzDirector
|
Exercise / conversionCommon Stock | 10,000 | $24.00 | $240,000.00 |
DisclosureSEC source: 0001415889-24-006998 · form4-03062024_040303.xml · nonDerivative · entry 2 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:05 UTC |
Requardt Hermann FritzDirector
|
Exercise / conversionCommon Stock | 5,000 | $18.15 | $90,750.00 |
DisclosureSEC source: 0001415889-24-006998 · form4-03062024_040303.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 4,641 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · derivative · entry 11 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,641 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 4,384 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · derivative · entry 10 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,384 shares Expires 2028-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 7,097 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · derivative · entry 9 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,097 shares Expires 2026-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 12,000 | $0.00 Strike: $19.82 | $0.00 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · derivative · entry 8 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2025-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
SaleCommon Stock | 1,500 | $84.48 | $126,720.00 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 7 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,859 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.46 to $84.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
SaleCommon Stock | 12,770 | $84.97 | $1,085,066.90 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 6 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,359 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.52 to $85.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
SaleCommon Stock | 13,852 | $86.06 | $1,192,103.12 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 5 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,129 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.52 to $86.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionCommon Stock | 4,641 | $41.95 | $194,689.95 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 4 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionCommon Stock | 4,384 | $34.02 | $149,143.68 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 3 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionCommon Stock | 7,097 | $22.19 | $157,482.43 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 2 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC |
Busse FalkoPRESIDENT, BIOSPIN GROUP
|
Exercise / conversionCommon Stock | 12,000 | $19.82 | $237,840.00 |
DisclosureSEC source: 0001415889-24-006070 · form4-03012024_040301.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · PRESIDENT, BIOSPIN GROUP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 618 | $0.00 Strike: $62.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · derivative · entry 9 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,854 Underlying: Common Stock · 2,472 shares Expires 2032-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option granted to the Reporting Person on August 11, 2022 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,903 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · derivative · entry 8 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,903 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,846 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · derivative · entry 7 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 923 Underlying: Common Stock · 2,769 shares Expires 2030-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option granted to the Reporting Person on August 6, 2020 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,083 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · derivative · entry 6 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,083 shares Expires 2028-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
SaleCommon Stock | 15,319 | $83.30 | $1,276,072.70 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · nonDerivative · entry 5 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,065 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.64, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionCommon Stock | 618 | $62.00 | $38,316.00 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · nonDerivative · entry 4 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionCommon Stock | 1,903 | $41.95 | $79,830.85 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · nonDerivative · entry 3 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionCommon Stock | 1,083 | $34.02 | $36,843.66 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · nonDerivative · entry 2 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:02 UTC |
Prause BurkhardPRES. & CEO, BRUKER BEST
|
Exercise / conversionCommon Stock | 1,846 | $43.50 | $80,301.00 |
DisclosureSEC source: 0001415889-24-005215 · form4-02262024_090205.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · PRES. & CEO, BRUKER BEST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:05 UTC |
ORNELL JOHN ADirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000852 · form4-01092024_090146.xml · nonDerivative · entry 1 ORNELL JOHN A · CIK 0001186875 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,147 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:05 UTC |
ROSENTHAL BOBDirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000851 · form4-01092024_090116.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,147 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:04 UTC |
Friend Cynthia MDirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000850 · form4-01092024_090147.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,953 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:04 UTC |
Ma PhilipDirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000849 · form4-01092024_090121.xml · nonDerivative · entry 1 Ma Philip · CIK 0001919486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,963 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:03 UTC |
Perkins Adelene QDirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000848 · form4-01092024_090151.xml · nonDerivative · entry 1 Perkins Adelene Q · CIK 0001375124 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,326 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:03 UTC |
LINTON WILLIAM ADirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000847 · form4-01092024_090117.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,425 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:02 UTC |
Requardt Hermann FritzDirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000846 · form4-01092024_090148.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,147 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:02 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000845 · form4-01092024_090115.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,254 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:01 UTC |
Anderson Bonnie HDirector
|
GrantCommon Stock | 2,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000844 · form4-01092024_090134.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,029 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:02 UTC |
Srega JuergenPRESIDENT CALID
|
Tax withholdingCommon Stock | 4,840 | $73.63 | $356,369.20 |
DisclosureSEC source: 0001415889-23-017009 · form4-12292023_091202.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · PRESIDENT CALID 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,791 Read SEC document |
| December 16, 2023 Filed Mar 12, 2024 20:05 UTC |
LAUKIEN FRANK HDirector · PRESIDENT & CEO · 10% owner
|
Tax withholdingCommon Stock | 1,404 | $73.36 | $102,997.44 |
DisclosureSEC source: 0001415889-24-007626 · form4-03122024_040301.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · PRESIDENT & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,326,507 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.